Clinical Trial Update: Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating Talimogene laherparepvec with radiation therapy in newly diagnosed soft tissue sarcoma resectable by surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma
• Soft Tissue Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Talimogene laherparepvec (T-VEC) (talimogene laherparepvec)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leiomyosarcoma, Liposarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING